IMPORTANCE Understanding patients' perceptions of symptoms and outcomes of urogynecologic surgery is essential for providing high-quality care. OBJECTIVE The aim of the study was to assess association of pain catastrophizing with pelvic floor symptom distress and impact, postoperative pain, and voiding trial in patients undergoing urogynecologic surgery. STUDY DESIGN Individuals whose self-identified gender was female and were undergoing surgery March 2020-December 2021 were included. Participants completed the Pain Catastrophizing Scale (range 0-52), Pelvic Floor Distress Inventory, and Pelvic Floor Impact Questionnaire preoperatively. Pain catastrophizing was score ≥30 and describes the tendency to magnify the overall threat of pain. Voiding trial failure was inability to void ≥2/3 of instilled volume (≤300 mL). The association between pain catastrophizing and symptom distress and impact was assessed with linear regression. A P < 0.05 is significant. RESULTS Three hundred twenty patients were included (mean age, 60 years, 87% White). Forty-six of 320 participants (14%) had a pain catastrophizing score ≥30. The pain catastrophizing group had higher body mass index (33 ± 12 vs 29 ± 5), more benzodiazepine use (26% vs 12%), greater symptom distress (154 ± 58 vs 108 ± 60), and greater urogenital (59 ± 29 vs 47 ± 28), colorectal (42 ± 24 vs 26 ± 23), and prolapse (54 ± 24 vs 36 ± 24) subscale scores, all P ≤ 0.02. The pain catastrophizing group had greater impact (153 ± 72 vs 72 ± 64, P < 0.01) and urogenital (60 ± 29 vs 34 ± 28), colorectal (36 ± 33 vs 16 ± 26), and prolapse (57 ± 32 vs 22 ± 27) subscale scores, P < 0.01. Associations remained controlling for confounders ( P < 0.01). The pain catastrophizing group had higher 10-point pain scores (8 vs 6, P < 0.01) and was more likely to report pain at 2 weeks (59% vs 20%, P < 0.01) and 3 months (25% vs 6%, P = 0.01). Voiding trial failure did not differ (26% vs 28%, P = 0.98). CONCLUSIONS Pain catastrophizing is associated with greater pelvic floor symptom distress and impact and postoperative pain but not voiding trial failure.

中文翻译：

---

疼痛灾难化及其对盆底手术经验的影响。

重要性 了解患者对泌尿妇科手术症状和结果的看法对于提供高质量的护理至关重要。目的 该研究的目的是评估疼痛灾难化与接受泌尿妇科手术的患者盆底症状痛苦和影响、术后疼痛和排尿试验的关联。研究设计纳入了自认性别为女性且于 2020 年 3 月至 2021 年 12 月接受手术的个体。参与者在术前完成了疼痛灾难化量表（范围 0-52）、盆底不适量表和盆底影响问卷。疼痛灾难化评分≥30，描述了放大疼痛总体威胁的趋势。排尿试验失败是指无法排尿≥2/3 的滴注量（≤300 mL）。通过线性回归评估疼痛灾难化与症状困扰和影响之间的关联。AP < 0.05 是显着的。结果 纳入了 320 名患者（平均年龄 60 岁，87% 是白人）。320 名参与者中有 46 名 (14%) 的疼痛灾难性评分≥30。疼痛灾难化组的体重指数较高（33 ± 12 vs 29 ± 5），苯二氮卓类药物使用较多（26% vs 12%），症状痛苦更大（154 ± 58 vs 108 ± 60），以及泌尿生殖系统（59 ± 29）。与 47 ± 28）、结直肠（42 ± 24 与 26 ± 23）和脱垂（54 ± 24 与 36 ± 24）分量表评分，所有 P ≤ 0.02。疼痛灾难化组影响更大（153 ± 72 vs 72 ± 64，P < 0.01），泌尿生殖系统（60 ± 29 vs 34 ± 28）、结直肠（36 ± 33 vs 16 ± 26）和脱垂（57 ± 32 vs 22 ± 27) 子量表分数，P < 0.01。关联仍然控制着混杂因素（P < 0.01）。疼痛灾难化组的 10 分疼痛评分较高（8 vs 6，P < 0.01），并且更有可能在 2 周（59% vs 20%，P < 0.01）和 3 个月（25% vs 6%）时报告疼痛，P = 0.01）。排尿试验失败没有差异（26% vs 28%，P = 0.98）。结论 疼痛灾难化与更大的盆底症状痛苦和影响以及术后疼痛相关，但与排尿试验失败无关。